Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 1125-1131

  Xie, Qing ^a   Anderson, Amy S ^a   Morgan, Robin W ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY RNA;

ANIMAL CELL; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LYMPHOBLASTOID CELL; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; VIRAL GENETICS; VIRUS CELL TRANSFORMATION; VIRUS TRANSCRIPTION;

EID: 0030058672     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.1125-1131.1996     Document Type: Article

References (43)

1. Agrawal, S., J. Goodchild, M. P. Civeira, A. H. Thornton, P. S. Sarin, and P. C. Zamecnik. 1988. Oligodeoxynucleoside phosphoramidates and phosphorothioatcs as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85:7079-7083.
2. Anderson, A. S., A. Francesconi, and R. W. Morgan. 1992. Complete nucleotide sequence of the Marek's disease virus ICP4 gene. Virology 189:657-667
3. Ausubel, R. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. John Wiley & Sons. New York.
4. Baim, S. B., M. A. Labow, A. J. Levine, and T. Shenk. 1991. A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl β-D-thiogalactopyranoside. Proc. Natl Acad. Sci. USA 88:5072-5076.
5. Berlingieri, M. R., G. Manfioletti, M. Santoro, A. Bandiera, R. Visconti, V. Giancotti, and A. Fusco. 1995. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell. Biol. 15:1545-1553.
6. Bradley, G., M. Hayashi, G. Lancz, A. Tanaka, and M. Nonoyama. 1989. Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J. Virol. 63:2534-2542.
7. Bradley, G., G. Lancz, A. Tanaka, and M. Nonoyama. 1989. Loss of Marek's disease virus tumongenicity is associated with truncation of RNAs transcribed within BamHI-H J. Virol 63:4129-4135
8. Calnek, B. W., and R. L. Witter. 1991 Marek's disease, p 342-385. In B. W. Calnek (ed.), Diseases of poultry Iowa State University Press. Ames.
9. Cantello, J. L., A. S. Anderson, and R. W. Morgan. 1994. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J. Virol. 68:6280-6290
10. Chen, X., P. J. A. Sondermeijer, and L. F. Velicer. 1992. Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed m both lytically infected cells and latently infected lymphoblastoid tumor cells. J. Virol. 66:85-94.
11. Cui, Z., L. F. Lee, J.-L. Liu, and H.-J. Kung. 1991. Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J. Virol. 65:6509-6515.
12. Cui, Z., D. Yan, and L. F. Lee. 1990 Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins Virus Genes 3:309-322.
13. Fukuchi, K. A. Tanaka, L. W. Schierman, R. L. Witter, and M. Nonoyama. 1985. The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc. Natl Acad. Sci. USA 82:751-754
14. Gunning, P., J. Leavitt, G. Muscat, S.-Y. Ng, and L. Kedes. 1987. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts Proc. Natl. Acad Sci. USA 84:4831-4835.
15. Jones, D., L. Lee, J.-L. Liu, H.-J. Kung, and J. Tillotson. 1992. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad Sci. USA 89:4042-4046
16. Kawamura, M., M. Hayashi, T. Furuichi, M. Nonoyama, E. Isogai, and S. Namioka. 1991. The inhibitory effects of oligonucleotides complementary to Marek's disease virus mRNA transcribed from the BamHI-H region, on the proliferation of transformed lymphoblastoid cells, MDCC-MSBI. J. Gen. Virol. 72:1105-1111.
17. Labow, M. A., S. B. Bairn, T. Shenk, and A. J. Levine. 1990 Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells Mol. Cell Biol. 10:3343-3356.
18. Lemaitre, M., B. Bayard, and B. Lebleu. 1987 Specific antiviral activity of a poly (L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to VSV N protein mRNA initiation site. Proc. Natl Acad. Sci. USA 84:648-652.
19. Li, D.-S., J. Pastorek, V. Zelnik, G. D. Smith, and L. J. N. Ross. 1994 Identification of novel transcripts complementary to the Marek's disease virus homologue of the ICP4 gene of herpes simplex virus. J. Gen. Virol. 75:1713-1722.
20. Maotani, K., A. Kanamori, K. Ikuta, S. Ueda, S. Kato, and K. Hirai. 1986. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J. Virol. 58:657-660.
21. Marcus-Sekura, C. J. 1988. Techniques for using antisense oligodeoxyribonucleotides to study gene expression. Anal. Biochem. 172:289-295.
22. Matsukura, M., G. Zon, K. Shinozuka, M. Rubert-Guroff, T. Shimada, C. A. Stein, H. Mitsuya, F. Wong-Staal, J. S. Cohen, and S. Broder. 1989. Regulation of viral expression of HIV in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc. Natl. Acad. Sci. USA 86:4244-4248.
23. McKie, E. A., E. Ubukata, S. Hasegawa, S. Zhang, M. Nonoyama, and A. Tanaka. 1995. The transcripts from the sequences flanking the short component of Marek's disease virus during latent infection form a unique family of 3′-coterminal RNAs J. Virol. 69:1310-1314.
24. Miroshnichenko, O. I., T. I. Ponomareva, and T. I. Tikhonenko. 1989 Inhibition of adenovirus 5 replication in COS-1 cells by antisense RNAs against the viral E1a region. Gene 84:83-89.
25. Ono, M., Y. Kawaguchi, K. Maeda, N. Kamiya, Y. Tohya, C. Kai, M. Niijura, and T. Mikami. 1994 Nucleotide sequence analysis of Marek's disease virus (MDV) serotype 2 homolog of MDV serotype 1 pp38, an antigen associated with transformed cells. Virology 201:142-146.
26. Peng, F., J. Donovan, S. Specter, A. Tanaka, and M. Nonoyama. 1993. Prolonged proliferation of primary chicken embryo fibroblasts transfected with cDNAs from the BamHI-H gene family of Marek's disease virus. Int. J. Oncol. 3:587-591.
27. Pratt, W. D., J. Cantello, R. W. Morgan, and K. A. Schat. 1994. Enhanced expression of the Marek's disease virus-specific phosphoproteins pp38/41 after stable transfection of MSB-1 cells with the Marek's disease virus homolog of ICP4. Virology 201:132-136.
28. Qian, Z., P. Brunovskis, F. Rauscher III, L. Lee, and H.-J. Kung. 1995. The transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J. Virol 69:4037-4044.
29. Raviprakash, K., K. Liu, M. Matteucci, R. Wagner, R. Riffenburgh, and M. Carl. 1995. Inhibition of dengue virus by novel, modified antisense oligonucleotides. J. Virol. 69:69-74.
30. Rhodes, A., and W. James. 1990. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA J. Gen Virol 71:1965-1974.
31. Ripalti, A., M. C. Boccuni, F. Campanini, and M. P. Landini. 1995. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol. 69:2047-2057.
32. Roth, G., T. Curiel, and J. Lacy. 1994 Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells. Blood 84:582-587.
33. Schat, K. A., C.-L. Chen, W. R. Shek, and B. W. Calnek. 1982. Surface antigens on Marek's disease lymphoblastoid cell lines. JNCI 69:715-720.
34. Schat, K. A., W. D. Pratt R. W. Morgan, D. Weinstock, and B. W. Calnek. 1992 Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 36:432-439.
35. Sczakiel, G., M. Oppenlander, K. Rittner, and M. Pawlita. 1992. Tat- and Rev-directed antisense RNA expression inhibits and abolishes replication of human immunodeficiency virus type 1: a temporal analysis. J. Virol. 66:5576-5581.
36. Silva, R. F., and R. L. Witter. 1985. Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage. J. Virol. 54:690-696.
37. Smith, C. C., L. Aurelian, M. P. Reddy, P. S. Miller, and P. O. P. Ts'o. 1986. Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early premRNAs 4 and 5. Proc. Natl Acad Sci. USA 83:2787-2791
38. Smith, G. G., V. Zelnik, and L. J. N. Ross. 1994. Gene organization in herpesvirus of turkeys: identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology 207:205-216.
39. Stein, C. A., and Y.-C. Cheng. 1993. Antisense oligonucleotides as therapeutic agents is the bullet really magical? Science 261:1004-1012.
40. Sullenger, B. A., T. C. Lee, C. A. Smith, G. E. Ungers, and E. Gilboa. 1990. Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol. Cell. Biol. 10:6512-6523.
41. Szczylik, C., T. Skorski, N. C. Nicolaides, L. Manzella, L. Malaguarnera, D. Venturelli, A. Gewirtz, and B. Calabretta. 1991. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 253:562-565.
42. Talmage, D. A., and M. Listerud. 1994. Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene. Oncogene 9:3557-3563.
43. Zamecnik, P. C., and M. L. Stephenson. 1978 Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad. Sci USA 75:280-284.